comprehensive -WSS

comprehensive

author：focus 2025-09-27 13:11:19 - browse：85

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial

WSS

Delta passengers in Vegas fall sick while waiting on flight in triple

Experts study whether long Covid risk adds up with each reinfection

Senate HELP committee spars over health care workforce policies

Experts study whether long Covid risk adds up with each reinfection

Lasker Awards 2023: Winners in biomedical research

Thermo Fisher plant for manufacturing gene therapies to expand

hotspot

comprehensive

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Experts study whether long Covid risk adds up with each reinfection

DIEP, the 'gold standard' of breast reconstruction, is under threat

In rare move, senator releases unverified FBI source report alleging Biden bribe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How AI helped researchers track recovery from depression

Bright Health sells Medicare Advantage business to Molina

Stanford president’s abrupt resignation sparks debate

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Caribou posts encouraging results on off

focus

How AI helped researchers track recovery from depression

Experts study whether long Covid risk adds up with each reinfection

Changes to biosimilar regulatory framework must prioritize patients

Lasker Awards 2023: Winners in biomedical research

'CMA Fest' 2023: How to watch, who is performing and more

Why are Kaiser Permanente staff considering a strike?

focus

entertainment

entertainment

knowledge